✦ LIBER ✦
A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3
✍ Scribed by Alexandra Leary; L. Assersohn; D. Cunningham; A. R. Norman; G. Chong; G. Brown; P. J. Ross; C. Costello; L. Higgins; J. Oates
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 310 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.